Related Experiment Video

Updated: Feb 22, 2026

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
08:51

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling

Published on: June 25, 2015

9.7K

Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein-protein interactions and cancer therapy

Meng Gao1,2,3,4, Jingjing Zhou1,2,3,4, Zhengding Su1,2,3,4

  • 1Institute of Biomedical and Pharmaceutical Sciences, Hubei University of Technology, Wuhan, China.

Protein Science : a Publication of the Protein Society
|September 30, 2017
PubMed

Insights

Azurin, an anticancer bacteriocin from Pseudomonas aeruginosa, targets multiple pathways in cancer cells, offering a promising strategy to overcome therapy resistance. Further research into azurin and similar bacteriocins can enhance cancer treatment options.

Area of Science:

  • Microbiology
  • Biochemistry
  • Oncology

Background:

  • Azurin, a bacteriocin from Pseudomonas aeruginosa, demonstrates anticancer properties by selectively targeting human cancer cells.
  • It acts as a multi-target agent, interfering with critical cellular pathways like p53 signaling and non-receptor tyrosine kinases.
  • This multi-targeting mechanism suggests potential to overcome therapeutic resistance.

Purpose of the Study:

  • To review the anticancer mechanisms of azurin and azurin-like bacteriocins.
  • To explore how these agents interact with cellular regulators and signaling networks.
  • To highlight future research directions, including structural and post-translational modification studies.

Main Methods:

  • Literature review of studies on azurin and related bacteriocins.
  • Analysis of signaling pathways affected by azurin, including p53 and tyrosine kinases.
  • Discussion of therapeutic applications and potential for overcoming drug resistance.

Main Results:

  • Azurin induces apoptosis and growth inhibition in cancer cells.
  • It modulates key cellular signaling pathways, acting on multiple targets.
  • Azurin-derived peptides show therapeutic potential.

Conclusions:

  • Azurin and similar bacteriocins represent a promising therapeutic avenue for cancer treatment.
  • Understanding their mechanisms, including structural interactions with targets like p53, is crucial.
  • Further investigation may lead to novel strategies to combat cancer and overcome resistance.
Keywords:
Anticancer drugsbacterial proteinsnon-receptor tyrosine kinasesp53tumor suppression

More Related Videos

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds07:13

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds

Published on: August 8, 2025

1.7K
Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria08:22

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria

Published on: May 16, 2025

603

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
750
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
41.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.8K